Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood protein may reveal hidden insulin problems

NCT ID NCT01648478

Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a protein called IRAP, found in the blood, can be used as a marker for insulin sensitivity (how well the body uses insulin). Researchers measured IRAP levels in 21 healthy adults during a special test called a hyperinsulinemic-euglycemic clamp, which is the gold standard for measuring insulin sensitivity. The goal was to see if IRAP levels match the results of the clamp test, which could lead to a simpler blood test for insulin resistance in the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

21 people

The number who actually took part.

Start date

Jun 2012

Finished

Sep 2012

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men and women (sex ratio = 1) * Aged from 18 to 35 years * Fasting glycemia \< 6mmol/L * Total cholesterol \< 7mmol/L * Triglycerides \< 1.5 mmol/L * CRPus \< 5 mg/L * Creatinine clearance \< 80mL/min according to Cockroft formula * Liver enzymes (ALanine AminoTransférase and ASpartate AminoTransférase) \< 1.5 times normal values Exclusion Criteria: * Subject not in compliance with the recommendations of French National Law in force * Medical history of metabolic disease (diabetes, dyslipidemia), endocrine disease, renal insufficiency * Drug use that could affect glucose metabolism and the renin angiotensin aldosterone system * Blood pressure \> 140/90mmHg * Tea and coffee consumption more than 5 cups per day * Subject who smoke more than 5 cigarettes per day

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Insulin resistance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Insulin Resistance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Insulin resistance

Contacts and locations

Locations

  • Centre de recherche en nutrition humaine Rhone-Alpes

    Pierre-Bénite, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.